Liver Disease
AssigneeLipocine Inc.
InventorsMahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari, Burke Byrne, Kilyoung Kim, Jonathan A. Baker
Life of this patent
Estimating the term…
Abstract
Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described. One method comprises orally administering to a subject, a pharmaceutical composition having an amount of a testosterone, or an ester thereof, sufficient to treat the liver disease or condition, or symptom thereof.
Claims70
A pharmaceutical composition for treating at least one of cirrhosis, a condition thereof, and a symptom thereof, comprising at least one of a testosterone, a testosterone ester, a testosterone ester and tocopherol (TET) or a tocopherol derivative, and a combination thereof.
A Method of treating at least one of cirrhosis, a condition thereof, and a symptom thereof in a subject in need of treatment thereof comprising administering to said subject a pharmaceutical composition resulting in a therapeutically effective testosterone concentration in said subject.
A Method of treating at least one of cirrhosis, a condition thereof, and a symptom thereof in a subject in need of treatment thereof comprising administering to said subject a pharmaceutical composition comprising at least one of TU, TD, TT, TET, and a combination thereof.
The method of claim 609, wherein said glyceryl fatty acid comprises at least one of a glyceryl mono-fatty acid, a glyceryl di-fatty acid, and a glyceryl tri-fatty acid, and wherein said propylene glyceryl fatty acid comprises at least one of a propylene glyceryl mono-fatty acid, a propylene glyceryl di-fatty acid, and a propylene glyceryl tri-fatty acid.
Dependencies are inferred from the claim text.